Zobrazeno 1 - 9
of 9
pro vyhledávání: '"David A Folt"'
Autor:
Christopher, Di Felice, Pallavi, Sharma, David A, Folt, Rodney J, Folz, Frank, Jacono, Shine, Raju, Mohammad A, Shatat, Joanne, McKell, Anna, May, Maroun, Matta
Publikováno v:
South Med J
OBJECTIVE: A paucity of data exists on the role of the interview day in programs and applicants’ final rank list. The objective of our study was to investigate the impact interview day has on our programs and our interviewees’ final rank list. ME
Autor:
Steven T. Haller, David A Folt, Christopher J. Cooper, Sivarajan Kumarasamy, Joseph I. Shapiro, Siddhi Upadhyaya, Bina Joe
Publikováno v:
Circulation. 132
Introduction: Cd40 has been implicated in renal injury following activation by its ligand (sCD40L), which is released from activated platelets. Previously we have shown that patients with renal ischemia have elevated levels of sCD40L and circulating
Autor:
Leah M. Wuescher, Manish Karamchandani, Sivarajan Kumarasamy, Siddhi Upadhyaya, Thomas L. Saunders, Joseph I. Shapiro, Stanislaw M. Stepkowski, Steven T. Haller, Jiang Tian, Kyle Maxwell, Christopher J. Cooper, David A Folt, Harshal Waghulde, Bina Joe, Wanda E. Filipiak, Christopher A. Drummond, Blair Mell, Muhammad A. Chaudhry
Publikováno v:
Kidney international. 91(2)
High blood pressure is a common cause of chronic kidney disease. Because CD40, a member of the tumor necrosis factor receptor family, has been linked to the progression of kidney disease in ischemic nephropathy, we studied the role of Cd40 in the dev
Autor:
Lance D. Dworkin, Philip A. Kalra, Liliana Grinfeld, Pamela S. Brewster, David A Folt, Andrew Holden, Steven T. Haller, Wencan He, Sravya Brahmandam, Timothy P. Murphy, Kaleigh L. Evans, Shipeng Yu, Christopher J. Cooper, Kenneth Jamerson, Sheldon Tobe, Brian Rayner, William L. Henrich, Donald E. Cutlip, Kenneth R. Thomson
For people enrolled in Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL), we sought to examine whether variation exists in the baseline medical therapy of different geographic regions and if any variations in prescribing patterns were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45733fee82159a2d8bf6f11b8e8bac02
https://europepmc.org/articles/PMC4460564/
https://europepmc.org/articles/PMC4460564/
Autor:
David A Folt, Alan H. Matsumoto, Katherine R. Tuttle, Michael R. Jaff, Kaleigh L. Evans, Mark Shipeng Yu, Joseph I. Shapiro, Lance D. Dworkin, William L. Henrich, Karol M. Pencina, Christopher J. Cooper, Wencan He, Kaili Ren, Pamela S. Brewster, Donald E. Cutlip, Michael W. Steffes, Timothy P. Murphy
Publikováno v:
Circulation. 130
Introduction: Ischemic nephropathy due to atherosclerotic renal artery stenosis (ARAS) is associated with poor event free survival. However, previous studies suggest that stenosis severity has a poor relation to kidney function. We sought to test the
Autor:
Donald E. Cutlip, Michael W. Steffes, David A Folt, Michael R. Jaff, Timothy P. Murphy, Kaleigh L. Evans, William L. Henrich, Wencan He, Pamela S. Brewster, Kaili Ren, Christopher J. Cooper, Joseph I. Shapiro, Lance D. Dworkin
Publikováno v:
Circulation. 130
Introduction: Stenosis severity and revascularization may have little relation to outcomes in patients with atherosclerotic renal artery stenosis (ARAS). Albuminuria is a direct indicator of glomerular injury and kidney health. The effect of albuminu
Autor:
David A Folt, Kaleigh L. Evans, Christopher J. Cooper, Mark Shipeng Yu, Emily L. Cooper, Steven T. Haller, Christopher A. Drummond, Pamela Brewster
Publikováno v:
Current Atherosclerosis Reports. 16
The diagnosis of renal artery stenosis (RAS) has become increasingly common in part due to greater awareness of ischemic renal disease and increased use of diagnostic techniques. Over 90 % of RAS cases are caused by atherosclerotic renovascular disea
Autor:
Kenneth Jamerson, Lance D. Dworkin, Wencan He, David A Folt, Katherine R. Tuttle, Ralph B. D'Agostino, Pamela S. Brewster, Timothy P. Murphy, Christopher J. Cooper, Taylor Dawson, William L. Henrich, Kaleigh L. Evans, Donald E. Cutlip, Steven T. Haller
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 9(7)
People with atherosclerotic renal artery stenosis may benefit from renin-angiotensin inhibitors, angiotensin-converting enzyme inhibitors, and angiotensin-receptor blockers, but little is known about the factors associated with their use.The Cardiova
Autor:
Steven T, Haller, Kaleigh L, Evans, David A, Folt, Christopher A, Drummond, Christopher J, Cooper
Publikováno v:
Discovery medicine. 16(90)
Atherosclerotic renal artery stenosis (ARAS) is a common and complicated disease, which can result in high blood pressure and loss of kidney function. Although progress has been made in the understanding and treatment of hypertension in relation to A